Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study

Chronic myelomonocytic leukemia (CMML) is a rare and aggressive myeloid malignancy with overlapped features of myelodysplastic syndromes/myeloproliferative neoplasms. Azacitidine (AZA), a hypomethylating agent, has been approved for the treatment of CMML in China, but real-world data are limited. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yu, Guo, Rong, Miao, Miao, Zhang, Guangsen, Lan, Jianping, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395485/
https://www.ncbi.nlm.nih.gov/pubmed/35834039
http://dx.doi.org/10.1007/s10637-022-01283-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395485/
https://www.ncbi.nlm.nih.gov/pubmed/35834039
http://dx.doi.org/10.1007/s10637-022-01283-x

Ejemplares similares